Long COVID: what is known and what gaps need to be addressed
- PMID: 37434326
- PMCID: PMC10502447
- DOI: 10.1093/bmb/ldad016
Long COVID: what is known and what gaps need to be addressed
Abstract
Introduction: Long COVID is a chronic condition that follows after acute COVID-19 and is characterized by a wide range of persistent, cyclic symptoms.
Sources of data: PubMed search for publications featuring 'Long COVID' or 'post-acute sequelae of COVID-19'.
Areas of agreement: Long COVID occurs frequently post-acute COVID-19, with a majority of people experiencing at least one symptom (such as cough, fatigue, myalgia, anosmia and dyspnoea) 4 weeks after infection.
Areas of controversy: The specific symptoms and the minimum duration of symptoms required to be defined as Long COVID.
Growing points: There is a consistent reduction in Long COVID incidence amongst vaccinated individuals, although the extent of this effect remains unclear.
Areas timely for developing research: There is an urgent need to understand the causes of Long COVID, especially extreme fatigue more than 6 months after infection. We must understand who is at risk and whether reinfections similarly risk Long COVID.
Keywords: Long COVID; PASC; causes; symptoms; treatments.
© The Author(s) 2023. Published by Oxford University Press.
Conflict of interest statement
The authors have no potential conflicts of interest.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
